1,839
Views
0
CrossRef citations to date
0
Altmetric
Gastroenterology & Hepatology

Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease

ORCID Icon, , , ORCID Icon, ORCID Icon, , , & show all
Pages 1345-1353 | Received 02 Nov 2022, Accepted 15 Mar 2023, Published online: 28 Mar 2023

References

  • Rennemark M, Jogréus C, Elmståhl S, et al. Relationships between frequency of moderate physical activity and longevity: an 11-year follow-up study. Gerontol Geriatr Med. 2018;4:2333721418786565.
  • Cass SP. Alzheimer’s disease and exercise: a literature review. Curr Sports Med Rep. 2017;16(1):19–22.
  • Yaffe K, Barnes D, Nevitt M, et al. A prospective study of physical activity and cognitive decline in elderly women: women who walk. Arch Intern Med. 2001;161(14):1703–1708.
  • Valenza S, Paciaroni L, Paolini S, et al. Mild cognitive impairment subtypes and type 2 diabetes in elderly subjects. J Clin Med. 2020;9(7):2055.
  • Luchsinger JA, Reitz C, Patel B, et al. Relation of diabetes to mild cognitive impairment. Arch Neurol. 2007;64(4):570–575.
  • Pelimanni E, Jehkonen M. Type 2 diabetes and cognitive functions in middle age: a meta-analysis. J Int Neuropsychol Soc. 2018;25:1–16.
  • van den Berg E, Kloppenborg RP, Kessels RPC, et al. Type 2 diabetes mellitus, hypertension, dyslipidemia and obesity: a systematic comparison of their impact on cognition. Biochim Biophys Acta. 2009;1792(5):470–481.
  • van den Berg E, Reijmer YD, de Bresser J, et al. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58–65.
  • Xia MF, Bian H, Gao X. NAFLD and diabetes: two sides of the same coin? Rationale for gene-based personalized NAFLD treatment. Front Pharmacol. 2019;10:877.
  • Targher G, Byrne CD. Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab. 2013;98(2):483–495.
  • Younossi ZM. Non-alcoholic fatty liver disease – a global public health perspective. J Hepatol. 2019;70(3):531–544.
  • Seo SW, Gottesman RF, Clark JM, et al. Nonalcoholic fatty liver disease is associated with cognitive function in adults. Neurology. 2016;86(12):1136–1142.
  • Weinstein AA, de Avila L, Paik J, et al. Cognitive performance in individuals with non-alcoholic fatty liver disease and/or type 2 diabetes mellitus. Psychosomatics. 2018;59(6):567–574.
  • Qiu S, Cai X, Sun Z, et al. Association between physical activity and risk of nonalcoholic fatty liver disease: a meta-analysis. Therap Adv Gastroenterol. 2017;10(9):701–713.
  • Aune D, Norat T, Leitzmann M, et al. Physical activity and the risk of type 2 diabetes: a systematic review and dose–response meta-analysis. Eur J Epidemiol. 2015;30(7):529–542.
  • Liou WC, Chan L, Hong CT, et al. Hand fine motor skill disability correlates with dementia severity. Arch Gerontol Geriatr. 2020;90:104168.
  • Scherder E, Dekker W, Eggermont L. Higher-level hand motor function in aging and (preclinical) dementia: its relationship with (instrumental) activities of daily life – a mini-review. Gerontology. 2008;54(6):333–341.
  • Bossers WJR, van der Woude LHV, Boersma F, et al. A 9-week aerobic and strength training program improves cognitive and motor function in patients with dementia: a randomized, controlled trial. Am J Geriatr Psychiatry. 2015;23(11):1106–1116.
  • Buchman AS, Yu L, Wilson RS, et al. Physical activity, common brain pathologies, and cognition in community-dwelling older adults. Neurology. 2019;92(8):e811–e822.
  • Fleischman DA, Yang J, Arfanakis K, et al. Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology. 2015;84(13):1294–1300.
  • Hübner L, Voelcker-Rehage C. Does physical activity benefit motor performance and learning of upper extremity tasks in older adults? A systematic review. Eur Rev Aging Phys Act. 2017;14:15.
  • Olafsdottir HB, Zatsiorsky VM, Latash ML. The effects of strength training on finger strength and hand dexterity in healthy elderly individuals. J Appl Physiol (1985). 2008;105(4):1166–1178.
  • Pedroso RV, Lima-Silva AE, Tarachuque PE, et al. Efficacy of physical exercise on cortical activity modulation in mild cognitive impairment: a systematic review. Arch Phys Med Rehabil. 2021;102(12):2393–2401.
  • Gerber LH, Weinstein A, Pawloski L. Role of exercise in optimizing the functional status of patients with nonalcoholic fatty liver disease. Clin Liver Dis. 2014;18(1):113–127.
  • Golabi P, Locklear CT, Austin P, et al. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: systematic review. World J Gastroenterol. 2016;22(27):6318–6327.
  • Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16(10):545–555.
  • Schweitzer GG, Klein S. Exercise and NAFLD: is it worth the effort? Hepatology. 2017;66(5):1691–1694.
  • Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74.
  • Weinstein G, Zelber-Sagi S, Preis SR, et al. Association of nonalcoholic fatty liver disease with lower brain volume in healthy middle-aged adults in the Framingham study. JAMA Neurol. 2018;75(1):97–104.
  • Langa KM, Levine DA. The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. 2014;312(23):2551–2561.
  • Lafayette Instruments. Grooved Pegboard Test user instructions. Lafayette (IN): Lafayette Instrument Company; 2002.
  • Delis DC, Kaplan E, Kramer JH. Delis–Kaplan Executive Function System (D-KEFS): technical manual. San Antonio (TX): Harcourt Assessment Company; 2001.
  • Daughton DM, Fix AJ, Kass I, et al. Maximum oxygen consumption and the ADAPT Quality-Of-Life Scale. Arch Phys Med Rehabil. 1982;63(12):620–622.
  • Austin P, Gerber L, Paik JM, et al. Aerobic capacity and exercise performance in nonalcoholic fatty liver disease. J Sports Med Phys Fitness. 2019;59(8):1376–1388.
  • Price JK, Srivastava R, Bai C, et al. Comparison of activity level among patients with chronic liver disease. Disabil Rehabil. 2013;35(11):907–912.
  • Weinstein AA, Escheik C, Oe B, et al. Perception of effort during activity in patients with chronic hepatitis C and nonalcoholic fatty liver disease. Pm R. 2016;8(1):28–34.
  • Moore DS. The basic practice of statistics. New York (NY): Palgrave MacMillan; 2010.
  • Hulley SB, Cummings SR, Browner WS, et al. Designing clinical research. Philadelphia (PA): Wolters Kluwer/Lippincott Williams & Wilkins; 2013.
  • San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, et al. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy. J Clin Med. 2020;9(7):2154.
  • Gundmi S, Maiya AG, Bhat AK, et al. Hand dysfunction in type 2 diabetes mellitus: systematic review with meta-analysis. Ann Phys Rehabil Med. 2018;61(2):99–104.
  • Sayer AA, Dennison EM, Syddall HE, et al. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care. 2005;28(10):2541–2542.
  • Dai W, Ye L, Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine. 2017;96(39):e8179.
  • Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801.
  • Hazlehurst JM, Woods C, Marjot T, et al. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65(8):1096–1108.
  • Jäger S, Jacobs S, Kröger J, et al. Association between the fatty liver index and risk of type 2 diabetes in the EPIC-Potsdam study. PLOS One. 2015;10(4):e0124749.
  • Sargeant JA, Gray LJ, Bodicoat DH, et al. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis. Obes Rev. 2018;19(10):1446–1459.
  • Orci LA, Gariani K, Oldani G, et al. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol. 2016;14(10):1398–1411.
  • Khov N, Sharma A, Riley TR. Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(22):6821–6825.
  • Baršić N, Lerotić I, Smirčić-Duvnjak L, et al. Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. World J Gastroenterol. 2012;18(30):3945–3954.